Action MoonLake Immunotherapeut... - MLTX

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

45,70

Prix Achat

40,00

Prix Vente

46,97

Volume échangé

427 246

45,14 Fourchette du Jour 47,02

37,55 Plage de 52 semaines 64,98

Cap du marché

2,92B

Clôture Veille

46,88

Ouverture

46,63

Dernière Transaction

46.6

Dernière heure de transaction

Volume financier

US$ 19 673 437

VWAP

46,0471

Volume moyen (3 m)

296 742

Actions en circulation

63 905 198

Rendement du Dividende

Ratio Cours sur Bénéfices

-66,25

Bénéfice par action (BPA)

-0,69

Chiffre d'affairess

Bénéfice net

-44,08M

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Secteur

Blank Checks

Industrie

Pharmaceutical Preparations

Site Web

moonlaketx.com

Siège social

Grand Cayman, Cym

Fondé

2020

MoonLake Immunotherapeutics est coté dans le secteur Blank Checks de la NASDAQ avec le ticker MLTX. Le dernier cours de clôture d'MoonLake Immunotherapeut... était de US$46,88. Au cours de la dernière année, les actions de MoonLake Immunotherapeut... ont été négociées dans une fourchette de prix de US$ 37,55 à US$ 64,98.

MoonLake Immunotherapeut... compte actuellement 63 905 198 actions en circulation. La capitalisation boursière d'MoonLake Immunotherapeut... est de US$3,00 milliard. MoonLake Immunotherapeut... a un ratio cours/bénéfice (ratio PE) de -66.25.

Form 4 - Statement of changes in beneficial ownership of securities

MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab

New trials in three new indications have been initiated with the Nanobody® sonelokimab: Phase 3 VELA-TEEN trial in adolescent hidradenitis suppurativa (HS), Phase 2 LEDA trial in palmoplantar...

Form 8-K - Current report

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.87	1.94066473344	44.83	47.24	41.92	884094	45.79036925	CS
4	-8.09	-15.0399702547	53.79	56	41.27	506815	47.37066008	CS
12	-0.935	-2.00493191809	46.635	58.26	41.27	296742	49.61249209	CS
26	0.23	0.505828018474	45.47	58.26	39.36	289596	48.76570496	CS
52	-11.56	-20.1886133426	57.26	64.98	37.55	352187	47.9180745	CS
156	33.33	269.442198868	12.37	64.98	4.25	344794	43.03301793	CS
260	33.33	269.442198868	12.37	64.98	4.25	344794	43.03301793	CS

MLTX - Frequently Asked Questions (FAQ)

What is the current MoonLake Immunotherapeut... share price?

The current share price of MoonLake Immunotherapeut... is US$ 45,70

How many MoonLake Immunotherapeut... shares are in issue?

MoonLake Immunotherapeut... has 63 905 198 shares in issue

What is the market cap of MoonLake Immunotherapeut...?

The market capitalisation of MoonLake Immunotherapeut... is USD 3B

What is the 1 year trading range for MoonLake Immunotherapeut... share price?

MoonLake Immunotherapeut... has traded in the range of US$ 37,55 to US$ 64,98 during the past year

What is the PE ratio of MoonLake Immunotherapeut...?

The price to earnings ratio of MoonLake Immunotherapeut... is -66,25

What is the reporting currency for MoonLake Immunotherapeut...?

MoonLake Immunotherapeut... reports financial results in USD

What is the latest annual profit for MoonLake Immunotherapeut...?

The latest annual profit of MoonLake Immunotherapeut... is USD -44,08M

What is the registered address of MoonLake Immunotherapeut...?

The registered address for MoonLake Immunotherapeut... is P.O. BOX 309, UGLAND HOUSE, GRAND CAYMAN, 1104

What is the MoonLake Immunotherapeut... website address?

The website address for MoonLake Immunotherapeut... is moonlaketx.com

Which industry sector does MoonLake Immunotherapeut... operate in?

MoonLake Immunotherapeut... operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
EVAXEvaxion Biotech AS	US$ 5,99 (64,56%)	55,41M
ELABPMGC Holdings Inc	US$ 3,0901 (56,07%)	76,48M
PCLAPicoCELA Inc	US$ 4,60 (49,35%)	3,75M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
GODNUGolden Star Acquisition Corporation	US$ 3,11 (-75,82%)	17,51k
GODNGolden Star Acquisition Corporation	US$ 2,93 (-65,67%)	902,76k
NXTTNext Technology Holding Inc	US$ 1,37 (-54,93%)	2,56M
SGLYSingularity Future Technology Ltd	US$ 1,625 (-38,45%)	917,77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90,11 (-38,07%)	8
ACONAclarion Inc	US$ 0,0557 (28,94%)	811,91M
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
RIMEAlgorhythm Holdings Inc	US$ 0,0357 (4,69%)	284,97M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
NVDANVIDIA Corporation	US$ 142,62 (-3,12%)	232,88M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MoonLake Immunotherapeutics (MLTX) Cours

MoonLake Immunotherapeutics (MLTX)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de MoonLake Immunotherapeutics

MLTX Dernières nouvelles

MLTX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application